Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Efficacy, tolerability and practicality of use of inhaled methoxyflurane in patients with moderate-to-severe trauma-related pain rescued from hostile mountainous environments by the Helicopter Emergency Medical Service (HEMS) in Italy: METEORA Protocol

Trial Profile

Efficacy, tolerability and practicality of use of inhaled methoxyflurane in patients with moderate-to-severe trauma-related pain rescued from hostile mountainous environments by the Helicopter Emergency Medical Service (HEMS) in Italy: METEORA Protocol

Status: Recruiting
Phase of Trial: Phase III

Latest Information Update: 27 Mar 2019

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Methoxyflurane (Primary)
  • Indications Pain
  • Focus Therapeutic Use
  • Acronyms METEORA
  • Sponsors Mundipharma Research
  • Most Recent Events

    • 27 Mar 2019 According to a Mundipharma GmbH media release, first patient has been enrolled into the trial. Professor Franco Marinangeli is the lead investigator and Giovanni Sbrana (Grosseto Helicopter Emergency Medical Service) is a Principal Investigator.
    • 27 Mar 2019 Status changed from not yet recruiting to recruiting, according to a Mundipharma GmbH media release.
    • 18 Nov 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top